Evaxion A/S
EVAX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001828253
No open-market purchases or sales by Evaxion A/S insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $4.93M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Evaxion A/S changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 8 | 1 | 9 | +2 |
| Shares | 92.9K | 37.5K | 258.2K | +202.8K (+366.1%) |
| Value | $166.9K | $68.0K | $291.4K | +$192.4K (+194.5%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Evaxion A/S at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 118,722 | $134.2K | 0.00% |
| Moloney Securities Asset Management, LLC | 36,000 | $40.7K | 0.01% |
| Millennium Management LLC | 29,141 | $33.0K | 0.00% |
| Two Sigma Securities, LLC | 10,443 | $11.8K | 0.00% |
| Simplex Trading, LLC | 8,382 | $9.00K | 0.00% |
Sold out (3)
Institutions that held Evaxion A/S at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Ground Swell Capital, LLC | 18,071 | $32.5K |
| Pura Vida Investments, LLC | 16,842 | $29.9K |
| Citadel Advisors LLC | 1,485 | $2.67K |
Not filed for Q1 2023 yet (1)
Institutions that held Evaxion A/S at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Telemetry Investments, L.L.C. | 37,500 | $68.0K |